Related Experiment Video
Updated: Jan 12, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Autosomal recessive hypertrophic cardiomyopathy associated with variants in TRIM63
F Bonanni1, A Ballerini2, A Gozzini2
1Cardiology Unit, Meyer Children's Hospital IRCCS, Florence, Italy; Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy.
Insights
Recessive hypertrophic cardiomyopathy (HCM) can be caused by rare TRIM63 gene variants. Identifying these biallelic TRIM63 variants is crucial for early diagnosis and proactive clinical surveillance in affected individuals.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is predominantly associated with dominant variants in sarcomeric genes.
- Rare genes, such as TRIM63, are emerging as potential causes of recessive HCM.
- TRIM63 encodes an E3 ubiquitin-protein ligase involved in protein degradation pathways.
Purpose of the Study:
- To investigate the role of TRIM63 variants in the etiology of hypertrophic cardiomyopathy.
- To identify patients with recessive HCM caused by biallelic TRIM63 mutations.
- To characterize the clinical phenotype associated with TRIM63-related HCM.
Main Methods:
- Next-generation sequencing was performed on 517 adult patients with clinical HCM.
- Analysis focused on identifying biallelic variants in the TRIM63 gene.
- Clinical data, including disease onset, cardiac morphology, fibrosis, and ventricular function, were reviewed.
Main Results:
- Six index cases with biallelic TRIM63 variants (four homozygous, two compound heterozygous) were identified among 517 patients.
- TRIM63-related HCM presented with early onset, marked concentric hypertrophy, diffuse myocardial fibrosis, and progressive left ventricular dysfunction.
- No cardiac disease was observed in heterozygous relatives, suggesting a recessive inheritance pattern.
Conclusions:
- TRIM63-related hypertrophic cardiomyopathy is a rare but clinically distinct entity.
- Early identification of biallelic TRIM63 variants is essential for accurate diagnosis.
- Proactive clinical surveillance is warranted for individuals identified with TRIM63-related HCM.
Background:
Hypertrophic cardiomyopathy (HCM) is typically linked to dominant variants in sarcomeric genes, but rare minor genes, including TRIM63 coding for an E3 ubiquitin-protein ligase, have recently emerged as potential causes of recessive HCM.
Methods And Results:
Among 517 adult patients with clinical HCM who underwent next-generation sequencing, we found six index cases carrying biallelic TRIM63 variants-four homozygous and two compound heterozygous. They presented with early-onset disease, marked concentric hypertrophy, diffuse myocardial fibrosis, and progressive left ventricular dysfunction. One patient underwent heart transplantation. No cardiac disease was found in heterozygous relatives.
Conclusions:
TRIM63-related HCM is rare but clinically distinct. Early identification of TRIM63 homozygous and two compound heterozygous variants in HCM is crucial and warrants proactive clinical surveillance.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Pedigree Analysis

